The correlation between the protein content of nuclei and heat-induced cell killing was determined for HeLa cells with various levels of thermotolerance. Thermotolerance was induced by heating cells at 45°C for 15 or 30 min and then incubating them at 37°C for 5 or 24 h. This procedure resulted in four different levels of thermotolerance requiring up to 5 h of heat at 45°C to kill more than 90% of the most resistant cells. Upon exposure to 45°C, the increase in the protein content of isolated nuclei was proportionally less for thermotolerant cells. The difference between the initial increase in nuclear protein content for normal and thermotolerant cells was relatively small for shorter heating times but became clearly evident for longer heating exposures. The correlations between cell killing and nuclear protein content were not statistically different from controls for any of the various levels of thermotolerance. The correlation was measured over survival levels below 0.1 in thermotolerant cells. Because thermotolerant HeLa cells are very resistant to heat, previous studies had not tested the correlation to survival levels below a half-decade of cell killing. These results should resolve some of the conflicting observations reported in the literature and are consistent with the suggestion that heat-induced changes in binding of nuclear protein play a key role in the lethal effects of hyperthermia.
Skip Nav Destination
Research Article| May 01 1994
Heat-Shock-Induced Changes in Nuclear Protein and Cell Killing in Thermotolerant HeLa Cells
Radiat Res (1994) 138 (2): 286–290.
- Views Icon Views
- Share Icon Share
- Search Site
Joseph L. Roti Roti, Nazan Turkel; Heat-Shock-Induced Changes in Nuclear Protein and Cell Killing in Thermotolerant HeLa Cells. Radiat Res 1 May 1994; 138 (2): 286–290. doi: https://doi.org/10.2307/3578600
Download citation file:
Citing articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner
Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group
Hualin Zhang, Xiaodong Wu, Xin Zhang, Sha X. Chang, Ali Megooni, Eric D. Donnelly, Mansoor M. Ahmed, Robert J. Griffin, James S. Welsh, Charles B. Simone, II, Nina A. Mayr